secwatch.observer — SEC 8-K summary
======================================

Issuer:     Valion Bio, Inc. (VBIO)
CIK:        0001787740
Form:       8-K/A
Filed at:   2025-07-25T23:59:59+00:00
Accession:  0000950170-25-098773
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Tivic Health amends license deal with Statera; royalties payable in stock; lien up to $5.6M
--------------------------------------------------------------------------------

- Royalties may be paid in cash or Tivic securities at Tivic's discretion under the A&R License Agreement.
- Avenue Venture Opportunities Fund lien increased to up to $5.6 million (Payoff Amount).
- After initial fees and first milestone, 80% of subsequent payments go directly to Avenue until lien satisfied.
- Initial license fee already paid: $300K cash plus 945,785 common shares and convertible preferred shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025098773/0000950170-25-098773-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1787740/000095017025098773/tivc-20250618.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-098773

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer